Silibinin loaded inhalable solid lipid nanoparticles for lung targeting

References

• Abbad, S., et al., 2015. Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate. International journal of nanomedicine, 10, 305–320.
   PubMed Web of Science ®Google Scholar
• Akopyan, G. and Bonavida, B., 2006. Understanding tobacco smoke carcinogen NNK and lung tumorigenesis (Review). International journal of oncology, 29, 745–752.
   PubMed Web of Science ®Google Scholar
• Al, Q., et al., 2012. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. Journal of controlled release, 157 (3), 383–390.
   PubMed Web of Science ®Google Scholar
• Alivisatos, A.P., 1996. Semiconductor clusters, nanocrystals, and quantum dots. Science, 271 (5251), 933–937.
   Web of Science ®Google Scholar
• Amirsaadat, S., et al., 2017. Silibinin-loaded magnetic nanoparticles inhibit hTERT gene expression and proliferation of lung cancer cells. Artificial cells, nanomedicine, and biotechnology, 45 (8), 1649–1656.
   PubMed Web of Science ®Google Scholar
• Arcari, M., et al., 1992. A new inclusion complex of silibinin and beta-cyclodextrins: in vitro dissolution kinetics and in vivo absorption in comparison with traditional formulations. Bollettino chimico farmaceutico, 131, 205–209.
   PubMedGoogle Scholar
• Asadzadeh, F., et al., 2018. Central composite design optimization of zinc removal from contaminated soil. Using citric acid as biodegradable Chelant. Science reports, 8, 26–33.
   PubMed Web of Science ®Google Scholar
• Azeem, A., et al., 2009. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech, 10 (1), 69–76.
   PubMed Web of Science ®Google Scholar
• Bhalekar, M., Upadhaya, P., and Madgulkar, A., 2017. Formulation and characterization of solid lipid nanoparticles for an anti-retroviral drug darunavir. Applied nanoscience, 7 (1–2), 47–57.
   Web of Science ®Google Scholar
• Bhatnagar, S., et al., 2013. A non-surgical method for induction of lung cancer in Wistar rats using a combination of NNK and high dietary fats. Protoplasma, 250 (4), 919–929.
   PubMed Web of Science ®Google Scholar
• Bocca, C., et al., 1998. Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles. International journal of pharmaceutics, 175 (2), 185–193.
   Web of Science ®Google Scholar
• Brown, J., et al., 1950. Influence of particle size upon the retention of particulate matter in the human lung. American journal of public health and the nation’s health, 40 (4), 450–480.
   PubMed Web of Science ®Google Scholar
• Bunjes, H., Koch, M.H.J., and Westesen, K., 2003. Influence of emulsifiers on the crystallization of solid lipid nanoparticles. Journal of pharmaceutical sciences, 92 (7), 1509–1520.
   PubMed Web of Science ®Google Scholar
• Bunjes, H., Koch, M.H.J., and Westesen, K., 2000. Effect of particle size on colloidal solid triglycerides. Langmuir, 16 (12), 5234–5241.
   Web of Science ®Google Scholar
• Carmen, H., et al., 2007. Quantitation of Silibinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites. Journal of agricultural and food chemistry, 55 (7), 2532–2535.
   PubMed Web of Science ®Google Scholar
• Chen, D.B., et al., 2001. In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel. Chemical & pharmaceutical bulletin, 49 (11), 1444–1447.
   PubMed Web of Science ®Google Scholar
• Chopra, S., Patil, G., and Motwani, S., 2007. Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experimental design. European journal of pharmaceutics and biopharmaceutics, 66 (1), 73–82.
   PubMed Web of Science ®Google Scholar
• Chougule, M., Padhi, B., and Misra, A., 2007. Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics. International journal of nanomedicine, 2 (4), 675–688.
   PubMed Web of Science ®Google Scholar
• Costa, P., and Sousa Lobo, J.M., 2001. Modeling and comparison of dissolution profiles. European journal of pharmaceutical sciences, 13 (2), 123–133.
   PubMed Web of Science ®Google Scholar
• Dash, S., et al., 2010. Kinetic modelling on drug release from controlled drug delivery systems. Acta poloniae pharmaceutica, 67, 217–223.
   PubMed Web of Science ®Google Scholar
• Dejaegher, B., and Heyden, Y.V., 2011. Experimental designs and their recent advances in set-up, data interpretation, and analytical applications. Journal of pharmaceutical and biomedical analysis, 56 (2), 141–158.
   PubMed Web of Science ®Google Scholar
• Dhoranwala, K.A., Shah, P., and Shah, S., 2015. Formulation optimization of rosuvastatin calcium-loaded solid lipid nanoparticles by 32 full-factorial design. NanoWorld journal, 1, 112–121.
   Google Scholar
• Din, F.U., et al., 2017. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. International journal of nanomedicine, 12, 7291–7309.
   PubMed Web of Science ®Google Scholar
• Ebrahimnezhad, Z., et al., 2013. Inhibition of hTERT gene expression by Silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line. BioImpacts, 3 (2), 67–74.
   PubMedGoogle Scholar
• Emami, J., et al., 2015. Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design. Research in pharmaceutical sciences, 10 (1), 17–33.
   PubMed Web of Science ®Google Scholar
• Fernandes, C.A. and Vanbever, R., 2009. Preclinical models for pulmonary drug delivery. Expert opinion on drug delivery, 6 (11), 1231–1245.
   PubMed Web of Science ®Google Scholar
• Flaig, T.W., et al., 2007. Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells. International journal of cancer, 120 (9), 2028–2033.
   PubMed Web of Science ®Google Scholar
• Freeman, B.A., and Crapo, J.D., 1982. Biology of disease: free radicals and tissue injury. Laboratory investigation; a journal of technical methods and pathology, 47 (5), 412–426.
   PubMed Web of Science ®Google Scholar
• Garala, K.C., et al., 2013. Quality by design (QbD) approach for developing agglomerates containing racecadotril and loperamide hydrochloride by crystallo-co-agglomeration. Powder technology, 247, 128–246.
   Web of Science ®Google Scholar
• Ghadiri, M., et al., 2012. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. International journal of pharmaceutics, 424 (1–2), 128–137.
   PubMed Web of Science ®Google Scholar
• Gong, J., et al., 2012. Polymeric micelles drug delivery system in oncology. Journal of controlled release, 159 (3), 312–323.
   PubMed Web of Science ®Google Scholar
• Gouveia, L., et al., 2002. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. Journal of drug targeting, 10 (8), 607–613.
   PubMed Web of Science ®Google Scholar
• Gupta, B., et al., 2016. Effects of formulation variables on the particle size and drug encapsulation of imatinib-loaded solid lipid nanoparticles. AAPS PharmSciTech, 17 (3), 652–662.
   PubMed Web of Science ®Google Scholar
• Hao-Yang, L., et al., 2015. In vitro hemocompatibility and cytotoxicity evaluation of halloysite nanotubes for biomedical application. Journal of nanomaterials, 2015, 685323.
   Web of Science ®Google Scholar
• He, J., et al., 2007. Preparation, pharmacokinetics and body distribution of silymarin-loaded solid lipid nanoparticles after oral administration. Journal of biomedical nanotechnology, 3 (2), 195–202.
   Web of Science ®Google Scholar
• Helgason, T., et al., 2009. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). Journal of colloid and interface science, 1, 75–81.
   Web of Science ®Google Scholar
• Hippalgaonkar, K., et al., 2013. Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. Journal of ocular pharmacology and therapeutics, 29 (2), 216–228.
   PubMed Web of Science ®Google Scholar
• Jain, A.K., et al., 2011. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials, 32 (2), 503–515.
   PubMed Web of Science ®Google Scholar
• Jeans, A.R., et al., 2012. Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis. Antimicrobial agents and chemotherapy, 56 (10), 5180–5185.
   PubMed Web of Science ®Google Scholar
• Katara, R. and Majumdar, D.K., 2013. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery. Colloids and surfaces B: biointerfaces, 103, 455–462.
   PubMed Web of Science ®Google Scholar
• Kiruthiga, P.V., Pandian, S.K., and Devi, K.P., 2010. Silymarin protects PBMC against B(a)P induced toxicity by replenishing redox status and modulating glutathione metabolizing enzymes-an in vitro study. Toxicology and applied pharmacology, 247 (2), 116–128.
   PubMed Web of Science ®Google Scholar
• Kuen, C.Y., et al., 2017. Increased loading, efficacy and sustained release of Silibinin, a poorly soluble drug using hydrophobically-modified chitosan nanoparticles for enhanced delivery of anticancer drug delivery systems. Nanomaterials, 7 (11), 379.
   Web of Science ®Google Scholar
• Leroux, J.C., et al., 1994. New approach for the preparation of nanoparticles by an emulsification–diffusion method. European journal of pharmaceutics and biopharmaceutics, 41, 14–18.
   Web of Science ®Google Scholar
• Lili, W., et al., 2016. Preparation and characterization of loperamide-loaded dynasan 114 solid lipid nanoparticles for increased oral absorption in the treatment of diarrhea. Frontiers in pharmacology, 7, 332.
   PubMed Web of Science ®Google Scholar
• Lionberger, R.A., et al., 2008. Quality by design: concepts for ANDAs. The AAPS journal, 10 (2), 268–276.
   PubMed Web of Science ®Google Scholar
• Lorenz, D., et al., 1984. Pharmacokinetic studies with silymarin in human serum and bile. Methods and findings in experimental and clinical pharmacology, 6 (10), 655–661.
   PubMedGoogle Scholar
• Manjunath, K., Reddy, J.S., and Venkateswarlu, V., 2005. Solid lipid nanoparticles as drug delivery systems. Methods and findings in experimental and clinical pharmacology, 27 (2), 127–144.
   PubMed Web of Science ®Google Scholar
• Martins, S., et al., 2012. Multivariate design for the evaluation of lipid and surfactant composition effect for optimization of lipid nanoparticles. European journal of pharmaceutical sciences, 45 (5), 613–623.
   PubMed Web of Science ®Google Scholar
• Mehnert, W., and Mader, K., 2001. Solid lipid nanoparticles: production, characterization, and applications. Advanced drug delivery reviews, 47 (2–3), 165–196.
   PubMed Web of Science ®Google Scholar
• Mohandas, J., et al., 1984. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer research, 44 (11), 5086–5091.
   PubMed Web of Science ®Google Scholar
• Mukherjee, S., Ray, S., and Thakur, R., 2007. The current status of solid lipid nanoparticles. Pharmabit XV, 1, 53–60.
   Google Scholar
• Nandi, A. and Chatterjee, I.B., 1988. Assay of superoxide dismutase activity in animal tissues. Journal of biosciences, 3, 305–315.
   Web of Science ®Google Scholar
• Nguyen, J., et al., 2008. Effects of cellpenetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs. The journal of gene medicine, 10 (11), 1236–1246.
   PubMed Web of Science ®Google Scholar
• Nishiyama, N. and Kataoka, K., 2006. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacology & therapeutics, 112 (3), 630–664.
   PubMed Web of Science ®Google Scholar
• Poudel, B.K., et al., 2012. Formulation, characterization, and optimization of valsartan self-micro emulsifying drug delivery system using statistical design of experiments. Chemical and pharmaceutical bulletin, 60 (11), 1409–1418.
   PubMed Web of Science ®Google Scholar
• Pouton, C.W., 2006. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. European journal of pharmaceutical sciences, 29 (3–4), 278–287.
   PubMed Web of Science ®Google Scholar
• Ravanfar, R., et al., 2016. Preservation of anthocyanins in solid lipid nanoparticles: optimization of a microemulsion dilution method using the Placket-Burman and Box-Behnken designs. Food chemistry, 199, 573–580.
   PubMed Web of Science ®Google Scholar
• Reddy, B.S., 1992. Animal experimental evidence on macronutrients and cancer. In: M.S. Micozzi and T.E. Moon, eds. Macronutrients. New York, NY: Dekker, 33–54.
   Google Scholar
• Sangeetha, N., Aranganathan, S., and Nalini, N., 2010. Silibinin ameliorates oxidative stress-induced aberrant crypt foci and lipid peroxidation in 1, 2 dimethylhydrazines induced rat colon cancer. Investigational new drugs, 28 (3), 225–233.
   PubMed Web of Science ®Google Scholar
• Schubert, M.A. and Müller-Goymann, C., 2003. Solvent injection as a new approach for manufacturing lipid nanoparticles—evaluation of the method and process parameters. European journal of pharmaceutics and biopharmaceutics, 55 (1), 125–131.
   PubMed Web of Science ®Google Scholar
• Serrano, A.G. and Perez-Gil, J., 2006. Protein-lipid interactions and surface activity in the pulmonary surfactant system. Chemistry and physics of lipids, 141 (1–2), 105–118.
   PubMed Web of Science ®Google Scholar
• Shah, M., et al., 2012. Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride. Indian journal of pharmaceutical sciences, 74 (5), 434–442.
   PubMed Web of Science ®Google Scholar
• Shah, P., et al., 2021. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition. Drug delivery and translational research, 11 (3), 1166–1185.
   PubMed Web of Science ®Google Scholar
• Shah, M. and Pathak, K., 2010. Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 23 full-factorial design. AAPS PharmSciTech, 11 (2), 489–496.
   PubMed Web of Science ®Google Scholar
• Singh, R.P. and Agarwal, R., 2006. Prostate cancer chemoprevention by Silibinin: bench to bedside. Molecular carcinogenesis, 45 (6), 436–442.
   PubMed Web of Science ®Google Scholar
• Singh, B., Kaur, T., and Singh, S., 1997. Correction of raw dissolution data for loss of drug during sampling. Indian journal of pharmaceutical sciences, 59, 196–199.
   Google Scholar
• Singh, B. and Singh, S., 1998. A comprehensive computer program for study of drug release kinetics from compressed matrices. Indian journal of pharmaceutical sciences, 60, 313–316.
   Google Scholar
• Suarez, S. and Hickey, A.J., 2000. Drug properties affecting aerosol behavior. Respiratory care, 45 (6), 652–666.
   PubMedGoogle Scholar
• Townsend, M.H., et al., 2017. Non-small-cell lung cancer cell lines A549 and NCI -H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane. OncoTargets and therapy, 10, 1921–1932.
   PubMed Web of Science ®Google Scholar
• Triplett, M.D. and Rathman, J.F., 2009. Optimization of β-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique. Journal of nanoparticle research, 11 (3), 601–614.
   Web of Science ®Google Scholar
• Tuck, M.K., et al., 2009. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. Journal of proteome research, 8 (1), 113–117.
   PubMed Web of Science ®Google Scholar
• USFDA., 2003. Q1A(R2) stability testing of new drug substances and products [online]. Silver Sprig, MD: Food [online]. Silver Sprig, MD: Food and Drug Administration. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/Q1AR2-stability-testing-new-drug-substances-and-products [Accessed on 2 June 2020].
   Google Scholar
• Varghese, L., et al., 2005. Silibinin efficacy against human hepatocellular carcinoma. Clinical cancer research, 11 (23), 8441–8448.
   PubMed Web of Science ®Google Scholar
• Varshosaz, J., et al., 2010. Development and optimization of solid lipid nanoparticles of amikacin by central composite design. Journal of liposome research, 20 (2), 97–104.
   PubMed Web of Science ®Google Scholar
• Varshosaz, J., Tabbakhian, M., and Mohammadi, M.Y., 2010. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. Journal of liposome research, 20 (4), 286–296.
   PubMed Web of Science ®Google Scholar
• Venkateswarlu, V. and Manjunath, K., 2004. Preparation, characterization and In vitro release kinetics of clozapine solid lipid nanoparticles. Journal of controlled release, 95 (3), 627–638.
   PubMed Web of Science ®Google Scholar
• Welsch, C.W., 1995. Review of the effects of dietary fat on experimental mammary gland tumorigenesis: role of lipid peroxidation. Free radical biology & medicine, 18 (4), 757–777.
   PubMed Web of Science ®Google Scholar
• Wu, J.W., et al., 2007. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. Journal of pharmaceutical and biomedical analysis, 45 (4), 635–641.
   PubMed Web of Science ®Google Scholar
• Xiao, Y.Y., et al., 2005. Preparation of silybin-phospholipid complex and its bioavailability in rats. Acta pharmacologica sinica, 40, 611–617.
   Google Scholar
• Xiao-Yun, L., et al., 2011. Polymer nanoparticles. Progress in molecular biology and translational science, 104, 299–323.
   PubMed Web of Science ®Google Scholar
• Ye, B., et al., 2007. Induction of lung lesions in Wistar rats by 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanate. BMC cancer, 7 (1), 90.
   PubMed Web of Science ®Google Scholar
• Zeb, A., et al., 2017. High payload itraconazole-incorporated lipid nanoparticles with modulated release property for oral and parenteral administration. The journal of pharmacy and pharmacology, 69 (8), 955–966.
   PubMed Web of Science ®Google Scholar